Project Grant HT94252410302
Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $757K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
- The University of Massachusetts Medical School (UMASS Medical) was awarded a $3,854,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced biomedical research targeting human respiratory viruses and host sequences with respiratory-active RNAs. The award, effective from September 1, 2025 to August 31, 2029, supports UMASS Medical's specialized expertise in infectious disease research, genetic studies, and...
- This $7,707,792 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports RNA-based strategies for the prevention and treatment of alphavirus and hemorrhagic fever virus infections. The grant was awarded on September 15, 2024 to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA. As a prominent research institution, UMass Medical has extensive experience securing...
- The University of Massachusetts Amherst was awarded a $557,247 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from February 1, 2023 to January 31, 2026 to develop intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The Military Medical Research and Development program supports innovative medical research with...
- This federal Project Grant award of $707,438 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award was made on July 15, 2024 with a performance period ending on July 14, 2027. The prime awardee is the University of Massachusetts Medical School's Grants and Contracts Administration Division, which will conduct the research at their...
- This $381,312.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at the University of Massachusetts Medical School to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Massachusetts Medical School is the awardee and will be conducting the research through its Grants and...
- The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- The University of Massachusetts Medical School (UMMS) was awarded a $5,712,429 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "CRISPR-BASED ADIPOSE THERAPIES FOR ACCELERATED AGING IN IRRADIATED NONHUMAN PRIMATES". The project, which runs from July 1, 2025 to June 30, 2028, aims to develop advanced gene editing-based therapies to address the accelerated aging processes observed in nonhuman...
- This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
- The University of Massachusetts Medical School (UMASS Medical) has been awarded a $952,162 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, titled "Novel, Improved AAV Vectors for the Treatment of ALS", is for a research project focused on developing innovative adeno-associated virus (AAV) vector treatments for amyotrophic lateral sclerosis (ALS). The project will be performed in Worcester, MA from August...
- The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...